We recently bought Alexion Pharmaceuticals ($ALXN) in our Wagner Daily ETF and stock newsletter, and this post is an educational walk-through of the technical setup and subsequent trade management. We’ll start by taking a look at the daily chart as it appeared prior to our March 12 buy entry:
A tight consolidation near the highs, holding above the 20-day exponential moving average, put the setup on our radar as a potential Relative Strength Breakout play. On March 12 (one day later), newsletter subscribers were alerted to our breakout entry into ALXN when the price traded through our trigger price, above the $86.00 level. That day, the strong closing price and volume action confirmed the breakout:
After a few days of consolidation, ALXN followed through to the upside on March 21, allowing us to sell the position into strength and lock in a healthy 9% gain on a 2-week hold. We had an initial risk of about 4% on the trade, so we achieved a solid 2 to 1 reward to risk ratio:
To participate in our next big winner, subscribe to The Wagner Daily, our nightly ETF and stock newsletter, for less than $2 per day (based on annual subscription). Your full satisfaction is guaranteed.
Missed the initial breakout? Don't worry - there's still a chance to catch that rocket! Today, we're diving deep into…
Discover the three powerful buy signals flashing in the Nasdaq and learn how to profit from the surprising shift in…
Could Tesla (TSLA) be gearing up for a major bullish run? Veteran analyst Rick Pedicelli breaks down five critical technical…
Trade what you see, not what you think.
The tech sector has recently experienced a significant downturn, with the NASDAQ index plummeting, but for astute traders, such market…
In the high-stakes world of AI stocks, even giants can stumble. Join us as we dissect Nvidia's recent 35% correction…